Briefing: Lack of FDA Advisory Committees Raises Concerns

Strategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse.

Editorial Staff

March 9, 2026

1 min read

Updated 4 months ago

FDA is reportedly shunning advisory committees.

Concerns from drugmakers, patients, and doctors.

Potential implications for drug approval processes.